| Name |
Streptomyces netropsis (Finlay et al. 1951) Witt and Stackebrandt 1991 |
|
| Strain designation | DSM 40259 |
|
| Other collections | ATCC 23940; CBS 924.68; CCRC 13374; Chas. Pfizer Co. 2937; ETH 15974; HUT 6086; IFO 3123; IFO 12893; IPV 880; IPV 1720; ISP 5259; JCM 4063; JCM 4655; KCC S-0063; KCC S-0655; LMG 5979; NCIMB 9592; NCIMB 9855; NRRL B-2268; PSA 80; RIA 605; RIA 1184; Routien 4779 |
|
| Access in situ (sampling data) |
Source: Soil
Country of access: United States
Locality, State of access: Hudson (New York)
Date of access: Before 26-11-1986 |
|
| History | CECT, 1986 < DSMZ < E.B. Shirling, ISP < J. Routien, Chas. Pfizer & Co. |
|
| Growth conditions | Culture media: 118
Growth temperature (in °C): 30
Incubation time: 15d
Atmospheric needs: aerobic
Cultivation conditions for CECT strains |
|
| Metabolites production | netropsin (congocidine) |
|
| Restrictions | Risk group: 1
CECT MTA |
|
| Genetic data | 16S rRNA sequence: EF178671
Complete genome sequence: jgi.1205650 |
|
| Patents | US patent 2586762, production of congocidine |
|
| Delivery | | Freeze-dried culture | | Acticult® 3R | | Active culture rate A | | Genomic DNA |
Tarifas de presentaciones |
|
|
| La CECT sigue estándares de calidad para garantizar la viabilidad, pureza y autenticidad de las cepas que conserva. La información mostrada en esta ficha procede de diversas fuentes. Algunas de las propiedades no han sido necesariamente contrastadas por la CECT |